35
Participants
Start Date
December 31, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
March 31, 2013
dalfampridine-ER 10mg
Placebo
Kennedy Krieger Institute at Johns Hopkins University, Baltimore
University of Alabama at Birmingham, Birmingham
Cleveland Clinic, Cleveland
Detroit Clinical Research Center, Farmington Hills
Gillette Children's Specialty Healthcare, Saint Paul
Rehabilitation Institute of Chicago, Chicago
University of Missouri at Columbia, Columbia
UCLA/Orthopaedic Hospital Center for Cerebral Palsy, Los Angeles
Rancho Los Amigos National Rehabilitation Center, Downey
Rady Children's Hospital San Diego, San Diego
Swedish Medical Center, Seattle
Lead Sponsor
Acorda Therapeutics
INDUSTRY